药物发现市场规模、份额和成长分析（按流程、药物类型、技术、治疗领域、服务供应商和地区划分）－2026-2033年产业预测

全球药物研发市场预计到 2024 年将达到 804.2 亿美元，到 2025 年将达到 882.2 亿美元，到 2033 年将达到 1850.2 亿美元，预测期（2026-2033 年）的复合年增长率为 9.7%。

在全球疾病发病率上升、技术进步以及对个人化医疗需求激增的推动下，全球药物研发市场正经历显着的成长和创新。研发活动日益密集，重点在于发现新的药物标靶和开发有效的治疗方法。基因组学、蛋白质组学和计算生物学等多个领域的融合，使研究人员能够更深入地了解疾病机制，并加速药物研发进程。此外，高通量筛检、人工智慧和巨量资料分析等先进技术的应用，正在提高药物研发的效率和成功率。随着精准医疗和标靶治疗日益受到重视，全球药物研发市场预计将迎来显着成长。

全球药物研发市场驱动因素

推动全球药物研发市场发展的关键因素是慢性病和感染疾病的日益普及。癌症、心血管疾病和各种感染疾病等疾病发生率的不断上升，凸显了对创新有效治疗方案的迫切需求。这种日益增长的需求迫使製药公司和研究机构将资源投入药物倡议，从而促进研发进展，旨在开发新的治疗方法方法以应对这些紧迫的健康挑战。因此，对克服这些医疗挑战的关注为药物研发领域的投资和创新创造了有利环境。

全球药物研发市场面临的限制因素

全球药物研发市场面临的一大挑战是药物研发过程高成本且耗时漫长。从最初的化合物发现到最终核准，都需要在研究、临床试验以及监管审批等方面投入大量资金。这种复杂的法规结构，加上严格的安全性和有效性标准，导致药物研发週期漫长。这些因素增加了新药上市的成本，最终可能影响患者和医疗服务提供者获得药物的便利性和可负担性。

全球药物研发市场趋势

全球药物研发市场的一大显着趋势是人工智慧 (AI) 和机器学习 (ML) 技术的日益普及。这些先进工具能够有效率且自动化地分析大量资料集，进而改变药物研发格局。 AI 和 ML 演算法擅长解读复杂的生物资讯、识别复杂的模式以及预测药物与标靶的相互作用，从而显着缩短药物研发週期。此外，AI 驱动的虚拟筛检和分子建模能够提高识别潜在候选药物的准确性。这些先进技术的整合可望提高药物研发专案的效率、降低成本并提升成功率，进而促进创新高效疗法的研发。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 技术分析
• 案例研究
• Start-Ups分析
• 管道分析
• 临床试验分析
• 合作关係分析

全球药物研发市场规模：依製程及复合年增长率划分（2026-2033 年）

• 目标选择
• 目标检验
• 命中先导化合物
• 先导药物最适化
• 候选物质检验

全球药物研发市场规模（依药物类型及复合年增长率划分）（2026-2033 年）

• 小分子药物
• 大分子药物/生物製药

全球药物研发市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 高通量筛检
• 药物基因组学
• 奈米科技
• 组合化学
• 人工智慧/机器学习在药物发现的应用
• 其他的

全球药物研发市场规模（依治疗领域划分）及复合年增长率（2026-2033 年）

• 肿瘤学
• 神经病学
• 感染疾病
• 代谢性疾病
• 循环系统
• 胃肠病学
• 肺科
• 其他的

全球药物研发市场规模（按服务供应商划分）及复合年增长率（2026-2033 年）

• 製药和生物技术公司
• 受託研究机构（CRO）
• 研究中心和学术机构
• 政府和公共卫生机构

全球药物研发市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc
• Merck & Co., Inc.
• Curia Global（Albany Molecular Research Inc.）
• Charles River Laboratories
• Evotec SE
• Jubilant Life Sciences
• Labcorp（Convance, Inc.）
• GenScript Biotech Corporation
• Dr. Reddy's Laboratories Limited（Aurigene）
• WuXi AppTec
• Biocon Ltd（Syngene International Ltd）
• SRI International
• Viva Biotech Holdings
• Domainex
• Eurofins Scientific SE
• Hongkong Tigermed Co., Limited（Frontage Holdings Corporation）
• Piramal Pharma Ltd.
• Shanghai Medicilon Inc
• Sygnature Discovery
• Selvita SA

结论与建议

Global Drug Discovery Market size was valued at USD 80.42 Billion in 2024 and is poised to grow from USD 88.22 Billion in 2025 to USD 185.02 Billion by 2033, growing at a CAGR of 9.7% during the forecast period (2026-2033).

The Global Drug Discovery market is undergoing notable growth and innovation, fueled by an escalating incidence of diseases, technological advancements, and a surge in demand for personalized medicine. This market is experiencing intensified research and development activities focused on uncovering novel drug targets and formulating effective therapeutics. The convergence of diverse fields, including genomics, proteomics, and computational biology, is providing researchers with enhanced insights into disease mechanisms, thereby accelerating the drug discovery process. Furthermore, the application of cutting-edge technologies such as high-throughput screening, artificial intelligence, and big data analytics is improving both the efficiency and success rates in drug development. With an increasing emphasis on precision medicine and targeted therapies, the Global Drug Discovery market is set for substantial growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Market Segments Analysis

Global Drug Discovery Market is segmented by Process, Drug Type, Technology, Therapeutic Area, Service Provider and region. Based on Process, the market is segmented into Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation. Based on Drug Type, the market is segmented into Small Molecule Drugs and Large molecule drug/Biologic Drugs. Based on Technology, the market is segmented into High Throughput Screening, Pharmacogenomics, Nanotechnology, Combinational Chemistry, AI/ML in Drug Discovery and Others. Based on Therapeutic Area, the market is segmented into Oncology, Neurology, Infectious Diseases, Metabolic Disorders, Cardiology, Gastroenterology, Pulmonology and Others. Based on Service Provider, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Research Centers and Academic and Government and Public Health Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Discovery Market

A key factor propelling the Global Drug Discovery market is the rising prevalence of chronic and infectious diseases. The growing occurrence of conditions like cancer, cardiovascular diseases, and various infectious ailments underscores an urgent demand for innovative and effective therapeutic solutions. This heightened need compels pharmaceutical companies and research institutions to allocate resources towards drug discovery initiatives, fostering advancements in R&D aimed at developing novel treatments and therapies that cater to these pressing health challenges. Consequently, the focus on overcoming these medical hurdles creates an environment ripe for investment and innovation within the drug discovery sector.

Restraints in the Global Drug Discovery Market

A significant challenge facing the Global Drug Discovery market is the elevated costs and lengthy duration associated with the drug development process. The journey from the initial discovery of a compound to securing market approval demands considerable investment in research, clinical trials, and navigating regulatory pathways. This intricate regulatory framework, coupled with rigorous safety and efficacy standards, contributes to the protracted timelines involved in drug development. Such factors can drive up the expenses associated with bringing new drugs to market, ultimately impacting their accessibility and affordability for patients and healthcare providers alike.

Market Trends of the Global Drug Discovery Market

A prominent trend in the Global Drug Discovery market is the increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies. These cutting-edge tools are transforming the drug discovery landscape by allowing for the efficient and automated analysis of vast datasets. AI and ML algorithms excel at dissecting complex biological information, identifying intricate patterns, and predicting drug-target interactions, thus significantly shortening the drug discovery timeline. Additionally, AI-driven virtual screening and molecular modeling enhance precision in identifying viable drug candidates. This integration of advanced technologies is set to bolster efficiency, curtail costs, and elevate the success rates of drug development programs, driving the emergence of innovative and effective therapeutics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Technology Analysis
• Case Studies
• Startup Analysis
• Pipeline Analysis
• Clinical Trial Analysis
• Partnership Analysis

Global Drug Discovery Market Size by Process & CAGR (2026-2033)

• Market Overview
• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Lead Optimization
• Candidate Validation

Global Drug Discovery Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Small Molecule Drugs
• Large molecule drug/Biologic Drugs

Global Drug Discovery Market Size by Technology & CAGR (2026-2033)

• Market Overview
• High Throughput Screening
• Pharmacogenomics
• Nanotechnology
• Combinational Chemistry
• AI/ML in Drug Discovery
• Others

Global Drug Discovery Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Oncology
• Neurology
• Infectious Diseases
• Metabolic Disorders
• Cardiology
• Gastroenterology
• Pulmonology
• Others

Global Drug Discovery Market Size by Service Provider & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Research Centers and Academic
• Government and Public Health Agencies

Global Drug Discovery Market Size & CAGR (2026-2033)

• North America (Process, Drug Type, Technology, Therapeutic Area, Service Provider)
  • US
  • Canada
• Europe (Process, Drug Type, Technology, Therapeutic Area, Service Provider)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Process, Drug Type, Technology, Therapeutic Area, Service Provider)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Process, Drug Type, Technology, Therapeutic Area, Service Provider)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Process, Drug Type, Technology, Therapeutic Area, Service Provider)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curia Global (Albany Molecular Research Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evotec SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp (Convance, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Limited (Aurigene)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Ltd (Syngene International Ltd)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SRI International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viva Biotech Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Domainex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hongkong Tigermed Co., Limited (Frontage Holdings Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Pharma Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Medicilon Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sygnature Discovery
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Selvita SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations